Format

Send to

Choose Destination
See comment in PubMed Commons below
Health Aff (Millwood). 2011 Feb;30(2):302-11. doi: 10.1377/hlthaff.2010.0157.

Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder.

Author information

  • 1Division of Medical Ethics at the Weill Medical College of Cornell University, in New York City, NY, USA. jjfins@med.cornell.edu

Abstract

Deep brain stimulation-a novel surgical procedure-is emerging as a treatment of last resort for people diagnosed with neuropsychiatric disorders such as severe obsessive-compulsive disorder. The US Food and Drug Administration granted a so-called humanitarian device exemption to allow patients to access this intervention, thereby removing the requirement for a clinical trial of the appropriate size and statistical power. Bypassing the rigors of such trials puts patients at risk, limits opportunities for scientific discovery, and gives device manufacturers unique marketing opportunities. We argue that Congress and federal regulators should revisit the humanitarian device exemption to ensure that it is not used to sidestep careful research that can offer valuable data with appropriate patient safeguards.

PMID:
21289352
DOI:
10.1377/hlthaff.2010.0157
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center